1 min read

Innovation Award 2025

🎉 Congratulations to Magali Taulan-Cadars and Prisca Boisguerin for winning the 2025 Innovation « Coup de cœur » Award with their StabCFTR project, aiming to improve care for cystic fibrosis

🎉 Congratulations to Magali Taulan-Cadars and Prisca Boisguerin for winning the 2025 Innovation « Coup de cœur » Award with their StabCFTR project, aiming to improve care for cystic fibrosis patients.

🏆 The award was presented on July 8, 2025, at the 6th Innovation Afterwork hosted by the University of Montpellier at the beautiful Jardin des Plantes.

At Aceso Therapeutics we’re proud to support and advance this groundbreaking work towards IND trials and beyond.

🙏 Thank you to all our partners who make this possible: Montpellier Métropole, Région Occitanie, University of Montpellier, SATT AxLR, BIC, Eurobiomed, Créalia Occitanie, PhyMedExp, CNRS, and INSERM.

Category

Published

July 30, 2025

Reading time

1 min read

Topic

Recognition

Publication

Press Release

Keep reading

Related news & insights

San Diego convention Center: June 22 – 25 – 2026

We are preparing to raise funds, with part already secured, to complete our regulatory preclinical studies, with CTA submission targeted for late 2027.

SATT AxLR enters the capital of Aceso Therapeutics and supports the development of ACT-101 for cystic fibrosis

Montpellier, March 2026 — Aceso Therapeutics announces the entry of SATT AxLR into its capital, marking a new milestone in the development of its biotech focused on innovative therapies for

European Young Investigators Meeting (EYIM) – March 2026

European Young Investigators Meeting (EYIM) - 2026

Get in touch

Partner with us to redefine cystic fibrosis care.

Whether you’re an investor, strategic partner, or member of the scientific community — we’d be glad to talk.

Email

Headquarters

Montpellier, France